Understanding Family History of Stomach Cancer (FH of Gastric Cancer) is crucial for risk assessment and early detection. This page provides information on documenting family history of gastric neoplasm in clinical settings, including relevant medical coding terms and healthcare guidelines for accurate diagnosis and patient care. Learn about the importance of FH of Stomach Cancer in preventive healthcare and optimizing patient outcomes.
Also known as
Persons with potential health hazards
Relates to family history of various diseases, including cancer.
Malignant neoplasm of stomach
While not family history, codes specify stomach cancer location.
Genetic susceptibility to malignant neoplasm
Covers genetic predispositions to various cancers, not specific to stomach.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the family history of stomach cancer confirmed?
When to use each related code
| Description |
|---|
| Family history of stomach cancer |
| Hereditary diffuse gastric cancer |
| Personal history of stomach cancer |
Unspecified family history type (e.g., parent, sibling) may lead to incorrect Z80- code selection impacting risk adjustment.
Documenting gastric cancer type (e.g., diffuse, intestinal) is crucial for accurate coding and cancer registry reporting (C16.-).
Discrepancies between patient-reported and documented family history require clarification to ensure accurate code assignment (Z80 vs. personal history).
Q: How significant is family history of stomach cancer in risk stratification for gastric cancer, and what specific genetic factors should I consider in my assessment?
A: Family history of stomach cancer is a significant risk factor for gastric cancer, especially if multiple first-degree relatives (parents, siblings, children) are affected. Individuals with a family history of diffuse gastric cancer should be evaluated for germline CDH1 mutations, as this significantly increases their lifetime risk. For those with familial intestinal-type gastric cancer, while several genes have been implicated, none are currently routinely tested clinically. Consider implementing a more intensive surveillance program for patients with a strong family history, including upper endoscopy with biopsies. Explore how genetic counseling can provide personalized risk assessments and management recommendations based on family history and genetic testing results.
Q: What screening guidelines should I follow for patients with a family history of stomach cancer, considering both early-onset and late-onset disease in the family?
A: Screening guidelines for patients with a family history of stomach cancer are not universally standardized and should be individualized based on the specific family history. Early-onset gastric cancer in the family suggests a higher likelihood of hereditary cancer syndromes, warranting more aggressive screening, potentially starting at a younger age. Late-onset familial gastric cancer still elevates risk, but the screening approach may be more aligned with guidelines for average-risk populations, which currently do not recommend routine screening in the absence of other risk factors. Learn more about the role of endoscopic surveillance and consider discussing the benefits and risks of prophylactic gastrectomy with high-risk individuals, particularly those with identified CDH1 mutations.
Patient presents with concerns regarding family history of stomach cancer, also known as gastric cancer or gastric neoplasm. The patient reports a family history of gastric malignancy, prompting this evaluation for inherited cancer risk and appropriate screening recommendations. Detailed family history was obtained, documenting the relationship to the patient, age of diagnosis, and specific type of gastric cancer where available. This family history of stomach cancer increases the patient's risk for developing the disease and necessitates further discussion regarding risk stratification, genetic counseling, and potential surveillance strategies. Recommendations for upper endoscopy, with or without biopsies, will be considered based on the patient's individual risk profile, including age, ethnicity, and other contributing factors like H. pylori infection status. Medical decision-making regarding stomach cancer screening will adhere to established clinical guidelines and be documented thoroughly for medical billing and coding accuracy. The patient was educated on the importance of lifestyle modifications, including diet and smoking cessation, in mitigating their overall gastric cancer risk. Genetic testing may be explored to further assess inherited susceptibility. Follow-up appointment scheduled to review potential screening and surveillance options and address any further questions or concerns.